Stay updated on ARO-C3 in Renal Disease Clinical Trial
Sign up to get notified when there's something new on the ARO-C3 in Renal Disease Clinical Trial page.

Latest updates to the ARO-C3 in Renal Disease Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page adds a disease term 'Non-immunoglobulin-mediated membranoproliferative glomerulonephritis' and a Genetic and Rare Diseases Information Center resource, and deletes an old funding notice and revision note. These updates are informational and do not alter the study's design or displayed results.SummaryDifference0.6%

- Check23 days agoChange DetectedAdded a site-wide notice about government funding lapse and NIH Clinical Center operating status. Updated page revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check30 days agoChange DetectedThe glossary toggle is now visible, and QC-related labels were updated to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'. The revision note now shows 'Revision: v3.4.0' replacing the previous v3.3.4.SummaryDifference0.2%

- Check44 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check66 days agoChange DetectedNew study locations added in New South Wales and Victoria (Australia) and Busan, Daegu, and Gyeonggi-do (South Korea); several location listings were removed, and metadata fields Last Update Posted and Revision were updated.SummaryDifference0.7%

- Check73 days agoChange DetectedThe study status was updated to Completed, and the page now lists the actual primary completion date (2025-05-05) and study completion date (2025-10-31) along with related QC/update timestamps (2025-12-12 and 2025-12-16).SummaryDifference0.4%

Stay in the know with updates to ARO-C3 in Renal Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARO-C3 in Renal Disease Clinical Trial page.